Aura Biosciences, Inc. 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-179426
- Form type
- 10-Q
- CIK
- 0001501796
- Primary document
- https://www.sec.gov/Archives/edgar/data/1501796/000119312525179426/aura-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aura Biosciences, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-57.6M | - | - |
| Net Income | $-54.5M | - | - |
| Eps Basic | -1.01 | - | - |
| Eps Diluted | -1.01 | - | - |
| Cash And Equivalents | $107.4M | - | - |
| Total Assets | $204.4M | - | - |
| Total Liabilities | $29.8M | - | - |
| Shareholders Equity | $174.6M | - | - |
| Operating Cash Flow | $-44.1M | - | - |
| Capital Expenditures | $226,000 | - | - |